Blair William & CO Atri Cure, Inc. Transaction History

Blair William & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$32.99 - $43.25 $329 - $432	10 Added 0.16%	6,246 $222,000
Q3 2023 Nov 09, 2023	SELL	$41.12 - $57.73 $10,280 - $14,432	-250 Reduced 3.85%	6,236 $273,000
Q2 2023 Aug 11, 2023	SELL	$40.44 - $49.6 $12,819 - $15,723	-317 Reduced 4.66%	6,486 $320,000
Q1 2023 May 12, 2023	SELL	$35.87 - $47.22 $17,325 - $22,807	-483 Reduced 6.63%	6,803 $281,000
Q4 2022 Feb 10, 2023	BUY	$33.48 - $47.45 $243,935 - $345,720	7,286 New	7,286 $323,000
Q1 2018 May 15, 2018	SELL	$15.05 - $21.03 $157,122 - $219,553	-10,440 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$17.69 - $23.44 $569,618 - $754,768	-32,200 Reduced 75.52%	10,440 $190,000
Q3 2017 Nov 13, 2017	BUY	$20.0 - $24.23 $852,800 - $1.03 Million	42,640	42,640 $954,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.4B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.